Egetis Therapeutics: Granted rolling NDA review based on currently available clinical data - Redeye

Redeye has a positive take on the news that Egetis has been granted a rolling NDA review based on currently available clinical data, and that the rolling NDA review will commence by the end of the year.

Länk till analysen i sin helhet: https://www.redeye.se/research/1132260/egetis-granted-rolling-nda-review-based-on-currently-available-clinical-data?utm_source=finwire&utm_medium=RSS